Cathie Wood's Ark Invest Goes All In on Tempus AI!

Multi-Million Dollar Bet on Health-Tech Game Changer

Cathie Wood, the fearless leader of Ark Invest, is shaking things up again! This time, she's throwing big bucks at Tempus AI, the rising star in health-tech. Wood's not just playing around; she's making a statement with her latest multi-million dollar investment.

On May 28, 2025, Wood's Ark funds snapped up 251,080 shares of Tempus AI, known as TEM, worth a cool $13.9 million. They bought in right after a dip in the stock price, sticking to their guns with Ark's signature strategy of buying the dips. It's bold, it's risky, and it's pure Cathie Wood.

Tempus AI just went public, and they're using AI to revolutionize cancer care and other tough medical treatments. Wood's all about AI transforming industries, and healthcare is right in her sights. This investment screams her vision loud and clear.

This isn't a one-off move. Ark's been on a buying spree since June 2024, and with this latest purchase, their Tempus AI stake has skyrocketed to $284.8 million. That's the sixth-largest position in their ETFs and a whopping 5% of their entire portfolio. They're not messing around!

Here's the rundown of Cathie Wood and Ark Invest's top holdings in their Genomic Revolution ETF, ARKG:

🥇 Tempus AI $TEM
🥈 Crispr $CRSP
🥉 Twist $TWST

Ark's not stopping there. They've been snapping up shares in big names like Nvidia, AMD, and Intellia Therapeutics, while also trimming back on Tesla, Roblox, and CoreWeave. It's a high-stakes game of buy and sell, and Ark's playing to win.

And let's not forget, Ark Invest is also deep in the crypto game, holding major positions in shares like COIN and even running their own Bitcoin ETF, ARKB. Cathie Wood's not just investing; she's redefining the game!